Reprogramming of somatic cells by defined factors
Reprogramming of somatic cells by defined factors
批准号:
7432087
负责人:
Konrad Hochedlinger
金额:
$262.5万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-08-31
关键词:
AdultCell TherapyCell divisionCell fusionCellsDevelopmentEpigenetic ProcessFibroblastsGoalsHumanKineticsLeadMolecularMolecular Sequence AlterationMusNatureOocytesPatientsProtein OverexpressionPublishingReportingSomatic CellStagingTherapeuticTimebaseblastomere structurec-myc Genescell typeembryonic stem cellinduced pluripotent stem cellnuclear reprogrammingnuclear transfertranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nuclear reprogramming defines the dedifferentiation of adult cells into pluripotent
embryonic cells and has enormous therapeutic potential as it allows generating
genetically matched cells from patients for cell therapy. Reprogramming has so far been
achieved by nuclear transfer into oocytes and by cell fusion between embryonic cells and
somatic cells, two approaches that have serious technical or ethical limitations. Based on
recently published observations, we have generated so-called induced pluripotent stem
(iPS) cells directly from fibroblasts by retroviral overexpression of the transcription
factors Oct4, Sox2, c-myc and Klf4. In contrast to the previously reported iPS cells, our
iPS cells were indistinguishable from ES cells in their epigenetic state and developmental
potential. Several crucial questions were raised by these findings; (i) what is the sequence
of molecular changes that accompany nuclear reprogramming, (ii) what is the kinetics of
reprogramming and does it require cell division, (iii) are different cell types at different
differentiation stages equally amenable to reprogramming, and (iv) can human cells be
reprogrammed into iPS cells? Resolving these questions will be critical for understanding
the molecular nature of nuclear reprogramming and may lead to strategies that allow
efficient reprogramming of patient?s cells into pluripotent cells. The current limitations to
solve these questions are the low efficiency of direct reprogramming and the inability to
follow reprogramming in real time. We will tackle these questions by generating
?reprogrammable mice? in which every single cell can be reversibly induced to express
the four factors at levels necessary for reprogramming, and by attempting to reprogram
human cells. The goals of this proposal are thus to determine (i) the robustness and
kinetics of reprogramming, (ii) the hierarchy of transcriptional and epigenetic changes
that accompany nuclear reprogramming, (iii) the responsiveness of different cell types to
the four factors, and (iv) the feasibility of human reprogramming.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/ng.1110
发表时间:
2012-03-04
期刊:
NATURE GENETICS
影响因子:
30.8
作者:
[Stadtfeld, Matthias, Apostolou, Effie, Ferrari, Francesco, Choi, Jiho, Walsh, Ryan M., Chen, Taiping, Ooi, Steen S. K., Kim, Sang Yong, Bestor, Timothy H., Shioda, Toshi, Park, Peter J., Hochedlinger, Konrad]
通讯作者:
Hochedlinger, Konrad
DOI:
10.1038/nature08285
发表时间:
2009-08-27
期刊:
Nature
影响因子:
64.8
作者:
[]
通讯作者:
DOI:
10.1126/science.1162494
发表时间:
2008-11-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
[Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K]
通讯作者:
Hochedlinger K
DOI:
10.1016/j.stem.2008.08.003
发表时间:
2008-09-11
期刊:
Cell stem cell
影响因子:
23.9
作者:
[Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K]
通讯作者:
Hochedlinger K
DOI:
10.1038/ncb0511-497
发表时间:
2011-05
期刊:
NATURE CELL BIOLOGY
影响因子:
21.3
作者:
[Wu, Sean M., Hothedlinger, Konrad]
通讯作者:
Hothedlinger, Konrad
共 16 条
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency
-
批准号:10612799
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2021
-
负责人:Konrad Hochedlinger
-
依托单位:
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency
-
批准号:10094448
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2021
-
负责人:Konrad Hochedlinger
-
依托单位:
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency
-
批准号:10375350
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2021
-
负责人:Konrad Hochedlinger
-
依托单位:
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors
-
批准号:10633236
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2020
-
负责人:Konrad Hochedlinger
-
依托单位:
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors
-
批准号:10408751
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2020
-
负责人:Konrad Hochedlinger
-
依托单位:
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors
-
批准号:10032776
-
项目类别:
-
资助金额:$45.1万
-
财政年份:2020
-
负责人:Konrad Hochedlinger
-
依托单位:
Dissecting the molecular and functional role of Sox2 in synovial sarcoma
-
批准号:9237244
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2016
-
负责人:Konrad Hochedlinger
-
依托单位:
Dissecting the molecular and functional role of Sox2 in synovial sarcoma
-
批准号:9098093
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2016
-
负责人:Konrad Hochedlinger
-
依托单位:
Role of Sox2 in stomach development, regeneration and cancer
-
批准号:8484839
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2012
-
负责人:Konrad Hochedlinger
-
依托单位:
Role of Sox2 in stomach development, regeneration and cancer
-
批准号:8348185
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2012
-
负责人:Konrad Hochedlinger
-
依托单位:
Role of Sox2 in stomach development, regeneration and cancer
-
批准号:8703099
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2012
-
负责人:Konrad Hochedlinger
-
依托单位:
Role of Sox2 in stomach development, regeneration and cancer
-
批准号:8885812
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2012
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:8289369
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:8675745
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:8149963
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:8042392
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:9275260
-
项目类别:
-
资助金额:$56.23万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
Transcription Factor Induced Reprogramming
-
批准号:8466843
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2010
-
负责人:Konrad Hochedlinger
-
依托单位:
海外基金